Pharmacy Technicians, Advanced Techs Can Do More in the Pharmacy
Pharmacy Times
MARCH 24, 2024
Studies have shown that the presence of advanced pharmacy technicians in a pharmacy has a positive predictive validity to increased monthly immunizations.
Sat.Mar 23, 2024 - Fri.Mar 29, 2024
132 
Examining Trends in Long-Term Opioid Use, Importance of Pharmacist-Physician Collaboration
Drug Topics
MARCH 27, 2024
At APhA 2024, 2 posters looked into how collaboration between physicians and community pharmacists is crucial when it comes to opioid prescriptions, and current opioid use patterns among older adults.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What States are Doing to Regulate Pharmacy Benefit Managers
Drug Topics
MARCH 25, 2024
In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.
Navigating the Psychedelic Renaissance: Emerging Mental Health Therapies and the Pharmacist’s Role
Pharmacy Times
MARCH 27, 2024
Psychedelic medicines such as psilocybin, MDMA, ketamine, and LSD have been shown to have a significant impact on conditions such as major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder in clinical trials.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Examining Antibiotic Allergies, Pharmacists Role in Testing
Drug Topics
MARCH 25, 2024
Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.
GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable
STAT
MARCH 29, 2024
Diabetes drugs are too expensive in the U.S., and insulin is infamously six to 13 times more expensive here than in comparable high-income countries. And blockbuster GLP-1 drugs, too, could be a lot less expensive, according to an investigation published this week in JAMA Network Open, with a simple change: robust generic competition. The study, led by Melissa Barber, a Yale postdoctoral fellow, and conducted in collaboration with Doctors Without Borders, a nonprofit medical organization working
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults
Pharmacy Times
MARCH 27, 2024
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
BD to Increase Plastic Syringe Production After FDA Warns on Imports From China
Drug Topics
MARCH 28, 2024
Following quality concerns voiced by the FDA regarding plastic syringes made in China, medical technology company BD has announced it will increase its production of plastic syringes in the US.
Why researchers think human milk could repair the gut microbiome and reduce infections
STAT
MARCH 29, 2024
For babies who are breastfed, their first source of sustenance is filled with proteins, sugars, hormones, vitamins, and minerals — just the right amount of nutrients for an infant. That milk could also lower the risk of asthma , diabetes, and allergies. And it could make low-birth-weight, preterm babies up to 10 times less likely to develop necrotizing enterocolitis , a common intestinal disorder.
Diabetes management tools not worth the cost, study finds. But digital health companies push back on 'flawed' analysis
Fierce Healthcare
MARCH 24, 2024
A new analysis pours cold water on the effectiveness of widely used digital diabetes management solutions, stirring up discussion about how best to evaluate the growing market of digital health too | The Peterson Health Technology Institute's analysis assessed whether digital diabetes solutions improve users' health outcomes over "usual care.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Focus: Policy Edition - Overview of California's Stop Dangerous Pharmacies Act
Pharmacy Times
MARCH 27, 2024
Ron Lanton discusses California's Stop Dangerous Pharmacies Act, which aims to address understaffed chain pharmacies and reduce medication errors by implementing new regulations around pharmacy staffing, error reporting, and unsafe working conditions.
Moderna’s Next-Gen COVID-19 Vaccine Outperforms Spikevax in Phase 3 Trial
Drug Topics
MARCH 27, 2024
mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
STAT
MARCH 28, 2024
While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary. His former student Ali Ellebedy was gnawed by frustration as Covid shutdowns stalled his influenza research; it took until the summer, when mass vaccination planning hit his radar, before the same realization kicked in.
How Amazon Pharmacy is using AI to deliver medications faster as it expands same-day delivery
Fierce Healthcare
MARCH 26, 2024
Amazon Pharmacy expanded its same-day medication delivery service to New York City and Los Angeles, with plans to add a dozen more U.S. | Amazon Pharmacy expanded its same-day medication delivery service to New York City and Los Angeles, with plans to add a dozen more U.S. cities by the end of the year, the company announced Tuesday.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Approves Macitentan, Tadalafil Combination Tablet for PAH
Pharmacy Times
MARCH 25, 2024
The combination tablet (Opsynvi; Johnson & Johnson) can also be used for individuals with pulmonary arterial hypertension who are being treated with stable doses of macitentan and tadalafil as separate tables.
Ozempic, Other GLP-1 Therapies Caused Major Increase in Medicare Spending
Drug Topics
MARCH 29, 2024
After semaglutide and tirzepatide were approved, and ozempic use continues to rise, Medicare spending is also increasing because of a high demand for GLP-1 therapies.
STAT+: Why the world’s most expensive drug might not be all that overpriced
STAT
MARCH 28, 2024
The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason. But last year, its staff sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’
'Things get built and forgotten about': The challenging work of maintaining AI tools in clinical settings
Fierce Healthcare
MARCH 29, 2024
With AI being all the buzz in healthcare today, many questions about the technology still remain. Do clinicians understand and trust AI tools? Are algorithms accurate and free from bias? | At the 2024 SXSW conference, a panel on the future of AI in healthcare moderated by AMA President Jesse Ehrenfeld, M.D., discussed what's still needed for safer, more integrated and more impactful systems.
FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients
Pharmacy Times
MARCH 25, 2024
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
Addressing The Need for Better Access to CGM in Low-Income Areas
Drug Topics
MARCH 26, 2024
In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers addressed continuous glucose monitoring and its potential role in indigent communities.
STAT+: Steward Health Care has deal to sell doctor network to UnitedHealth
STAT
MARCH 26, 2024
Troubled hospital operator Steward Health Care, grappling with a financial crisis that’s engulfed its eight Massachusetts hospitals, has moved to shore up its finances by striking a deal to sell its nationwide physician network to insurance giant UnitedHealth’s Optum Care unit. The proposed sale of the doctors group, called Stewardship Health, is part of Steward’s plan to bolster its national system of 33 hospitals after the Dallas-based company last year fell behind in payi
In banner year, Lilly rewards CEO David Ricks with 24% boost in total pay to $26.6M
Fierce Pharma
MARCH 25, 2024
In 2023, Eli Lilly CEO David Ricks received a 24% boost in pay from $21.4 million to $26.6 million. The increase coincides with the company's booming sales.
FDA Approves Cobas Malaria to Help Reduce Risks Infections From Transfused Blood Products
Pharmacy Times
MARCH 26, 2024
The test scans whole blood samples from individual human donors for the 5 parasite species that can cause malaria in humans and detects Plasmodium RNA and DNA.
Examining Pharmacists Role in the Current Vaccine Landscape
Drug Topics
MARCH 26, 2024
Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.
STAT+: Some nonprofit hospitals spend less on charity care than they receive in tax breaks, new analysis shows
STAT
MARCH 26, 2024
A new study of hospitals’ charity care spending suggests nonprofit hospitals really aren’t that different from their for-profit counterparts. One major benefit of being a nonprofit hospital is receiving tax exemptions on property taxes, income taxes, and sales taxes. Experts told STAT that implies a “social contract” with taxpayers, where these hospitals will help take care of the most vulnerable.
Contract negotiations between Providence, Blue Shield of California go publicly south
Fierce Healthcare
MARCH 25, 2024
Providence has launched the first public salvo in a spat with Blue Shield of California over ongoing contract negotiations. | Providence has launched the first public salvo in a spat with Blue Shield of California over ongoing contract negotiations.
Vitamin A Derivative May Have a Significant Role in Wound Healing
Pharmacy Times
MARCH 25, 2024
Vitamin A regulates stem cell differentiation to manage wound healing, although risk of tumor growth may increase if differentiation does not occur.
Improving CVD Outcomes Through Better Recommendations, Patient Monitoring
Drug Topics
MARCH 27, 2024
Researchers detailed the FDA’s recommendations on low-dose aspirin and pharmacists’ role in cardiovascular practice transformation programs.
Disparities in donor acceptance rates point to need for more equitable heart transplant care
STAT
MARCH 25, 2024
When a patient is going through end-stage heart failure, the best treatment is to get a heart transplant. The basic steps are familiar: First a patient gets on the waiting list, and then the wait begins for the offers. In recent years, access to donor hearts has gone up thanks to a change in heart allocation policy, but there are still gender- and race-based disparities in the acceptance rate of a donor heart offer by transplant teams, according to new research published Monday in the Journal of
Nanoscope preps filing for retinitis pigmentosa gene therapy
pharmaphorum
MARCH 26, 2024
Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying genetic mutations.
FDA Issues Letters to 6 Companies for Unapproved, Misbranded OTC Analgesic Products
Pharmacy Times
MARCH 27, 2024
The agency warns consumers against using these products, which are marketed for topical use to relieve pain associated with cosmetic procedures.
Demographics Significantly Influence Common Customer Behavior at Community Pharmacies
Drug Topics
MARCH 29, 2024
Researchers found various reasons for why individuals chose a specific pharmacy and how they purchase OTC medication.
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
STAT
MARCH 25, 2024
It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines , which have saved millions of lives. You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective.
Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
Fierce Pharma
MARCH 26, 2024
After three years, the crown jewel of Merck’s $11.5 billion acqu | After three years, the crown jewel of Merck’s $11.5 billion acquisition of Acceleron is ready to pay dividends. With the FDA’s approval of Winrevair (sotatercept) to treat pulmonary arterial hypertension (PAH), Merck is set to launch the first disease-modifying treatment for the condition.
Let's personalize your content